|
[Related PubMed/MEDLINE]
Total Number of Papers: 105
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment. |
allo-SCT, cHL, CR, HID, MRD, NRM, PFS, PR, R/R, S/PD, URD |
| 2 |
2020 |
Cladribine vs other drugs in MS: Merging randomized trial with real-life data. |
ARR, RCTs, RRMS |
| 3 |
2020 |
Comparative study on allogeneic with autologous hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in the era of TKIs: a systematic review and meta-analysis. |
allo-HSCT, auto-HSCT, CIs, CMR, CR, HRs, ORs, OS, RFS, TKIs, TRM |
| 4 |
2020 |
Curative potential of fludarabine, melphalan, and non-myeloablative dosage of busulfan in elderly patients with myeloid malignancy. |
DFS, FLU/MEL, NRM, oral, OS |
| 5 |
2020 |
Haploidentical Hematopoietic Stem Cell Transplantation Versus Umbilical Cord Blood Transplantation in Hematologic Malignancies: A Systematic Review and Meta-Analysis. |
aGVHD, cGVHD, CI, Haplo-SCT, NRM, ORs, OS, PFS, UCBT |
| 6 |
2020 |
Haploidentical stem cell transplantation vs matched unrelated donor transplantation in adults with hematologic malignancies: a systematic review and meta-analysis. |
aGVHD, cGVHD, CI, Haplo-SCT, MSD, MUD-SCT, NRM, OR, OS, PFS |
| 7 |
2020 |
Impacts of water temperature on phosphorus release of sediments under flowing overlying water. |
ECTP |
| 8 |
2020 |
Pre-transplant cytoreductive therapy can improve overall survival of patients with MDS-AML but not MDS-EB2 receiving HLA-matched sibling donor peripheral blood stem cell transplantation. |
aGVHD, CR, DFS, HCT-CI, MDS, MSD-PBSCT, NRM, OS, PCT |
| 9 |
2020 |
The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation. |
CI, HCT, HR, OS |
| 10 |
2020 |
[Outcomes of 138 myelodysplastic syndrome patients with HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation]. |
aGVHD, DFS, HCT-CI, HMA, IPSS-R, MDS, MDS-EB2, MSD-PBSCT, NRM, OS |
| 11 |
2019 |
Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-Analysis. |
allo-SCT, AML, auto-SCT, FLT3-ITD, MSD, MUD, OS, PRT, RFS, TRM |
| 12 |
2019 |
Chimeric Antigen Receptor T-cell (CAR T) Therapy for Hematologic and Solid Malignancies: Efficacy and Safety-A Systematic Review with Meta-Analysis. |
CAR-T, CRR, CSER, ORR |
| 13 |
2019 |
Serum Lipoprotein Profile Is Associated With Protective Effects of Oral Contraceptive Use on Multiple Sclerosis Severity: A Cross-Sectional Study. |
APOE, DO, EDSS, LDL, MS, MSSS, OC, RRMS |
| 14 |
2019 |
The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review. |
CTC |
| 15 |
2019 |
Where youth matters-clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancer. |
ALNC, YWBC |
| 16 |
2018 |
Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017. |
allo-SCT, GVHD, MM, OS, TRM |
| 17 |
2018 |
Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation. |
aGvHD, aKIR, allo-HSCT, cGVHD, DFS, GVHD, GVL, HR, iKIR, KIR, NK cell, OR, OS |
| 18 |
2018 |
Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia. |
AML, NRM, OS, RFS |
| 19 |
2018 |
Removal of ciprofloxacin from aqueous solutions by ionic surfactant-modified carbon nanotubes. |
CIP, CNTs, CTAB, SDS |
| 20 |
2018 |
[Prognostic significance of early phase donor chimerism after allogeneic peripheral blood stem cell transplantation]. |
aGVHD, allo-PBSCT, cGVHD, DC, DFS, FDC, OS, PCR-STR |
| 21 |
2017 |
Central nervous system disease in pediatric acute myeloid leukemia: A report from the Children's Oncology Group. |
AML, CNS, DFS, EFS, EOI, i.t, OS, WBC |
| 22 |
2017 |
Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: A meta-analysis and systematic review. |
ACH, CI, CR, EEC, IUD, PR |
| 23 |
2017 |
High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission. |
allo-SCT, AML, cCR, DFS, HR, MRD, OS |
| 24 |
2017 |
Maintenance phase in psoralen-ultraviolet A phototherapy of early-stage mycosis fungoides. Acritically appraised topic. |
CAT, CR, MF, PUVA, RCTs, USCLC, UVL |
| 25 |
2017 |
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia. |
B-ALL, EFS, HR, OS |
| 26 |
2017 |
PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia. |
AML, DFS, OS, PIM-1 |
| 27 |
2017 |
Prognostic Parameters of Acute Myeloid Leukaemia at Presentation. |
AML, CR, HDT/SCT, OS, RFS |
| 28 |
2017 |
[Allogeneic hematopoietic stem cell transplantation for treatment of refractory and relapsed acute myeloid leukemia: outcomes and prognostic factors]. |
allo-HSCT, AML, cGVHD, DFS, GVHD, OS, TRM |
| 29 |
2017 |
[Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation with IBu Precondition Regimen in Treatment for 11 Patients with Low to Intermediate Risk Acute Myeloid Leukemia]. |
AML, auto-PBHSCT, BU, CR, DFS, IDA, OS, TRM |
| 30 |
2017 |
[The analysis of prognosis-associated factors in adults with acute promyelocytic leukemia]. |
APL, CR, DFS, OS |
| 31 |
2016 |
Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group. |
AML, CR, DFS, GO, GO, HCT, ITD-AR, TRM |
| 32 |
2016 |
Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin Lymphoma. |
FDG, HL, NRM, OS, PFS, SCT |
| 33 |
2016 |
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. |
allo-SCT, EFS, HL, NRM, RIC |
| 34 |
2016 |
Sequential DICE combined with l-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma. |
CR, DR, NK, OS, PFS, SCRT |
| 35 |
2016 |
The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis. |
IVIGs, MS, PRIMS |
| 36 |
2016 |
The fludarabine, cytarabine, and granulocyte colony-stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline-based therapy for the treatment of acute myeloid leukemia for patients with pre-existing cardiac disease. |
FLAG |
| 37 |
2016 |
Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA). |
CSI, HR, SWENOTECA |
| 38 |
2015 |
A modified busulfan and cyclophosphamide preparative regimen for allogeneic transplantation in myeloid malignancies. |
allo-HSCT, Flu, GVHD, HSCT, TRM |
| 39 |
2015 |
Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies. |
allo-HSCT, AML, CI, HR, HSCT, OS, RFS, TRM |
| 40 |
2015 |
Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT). |
ALWP, EBMT, GVHD, LFS, MAC, MK AML, NRM, OS, RIC, SCT |
| 41 |
2015 |
Prognostic value of CD56 in patients with acute myeloid leukemia: a meta-analysis. |
AML, CIs, CRR, DFS, HRs, OR, OS |
| 42 |
2015 |
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes. |
CI, CS, CT, MA, RT |
| 43 |
2015 |
[Analysis of prognosis in acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation]. |
allo-HSCT, AML, IFD, OS |
| 44 |
2015 |
[Comparison of outcomes of adult acute lymphoblastic leukemia patients underwent autologous and allogeneic hematopoietic stem cell transplantation]. |
ALL, allo-HSCT, auto-HSCT, MRD, OS |
| 45 |
2014 |
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group. |
AML, ITD, OS |
| 46 |
2014 |
Community based interventions for the prevention and control of tuberculosis. |
CBI, CHW, HIV, TB |
| 47 |
2014 |
FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia. |
AML, BCRP, DFS, FLT3-ITD, LRP, MLL-PTD, mRNA, MRP-1 |
| 48 |
2014 |
Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma. |
allo-HCT, DLBCL, NRM, OS, PS, sib, URD |
| 49 |
2014 |
Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey. |
BMI, HRQoL, MS, PA, PwMS |
| 50 |
2014 |
Relationship between cytomegalovirus (CMV) reactivation, CMV-driven immunity, overall immune recovery and graft-versus-leukaemia effect in children. |
CMV, GVL, HSCT, PCR |
| 51 |
2014 |
[Effect of autologous peripheral blood stem cell transplantation in 13 patients with AML1/ETO (+) acute myeloid leukemia]. |
APBSCT, LFS, OS |
| 52 |
2014 |
[Impact of graft versus host disease on outcome of allogeneic peripherial blood stem cell transplantation for leukemia]. |
allo-PBSCT, DFS, GVHD, OS, TRM |
| 53 |
2014 |
[Outcome and prognosis in acute myeloid leukemia patients treated with related peripheral blood hematopoietic stem cell transplantation]. |
LFS, OS, PBHSCT |
| 54 |
2014 |
[The clinical analysis of allogeneic hematopoietic stem cell transplantation from human leukocyte antigen-identical siblings in 95 patients with myelodysplastic syndrome]. |
aGVHD, allo-HSCT, AML, BU, cGVHD, CY, DFS, Flu, G-CSF, HLA, IPSS, MDS, NRM, OS, RA, RAEB, RAEB-t |
| 55 |
2013 |
The superiority of allogeneic hematopoietic stem cell transplantation from unrelated donor over chemotherapy for adult patients with high-risk acute lymphoblastic leukemia in first remission. |
ALL, allo-HSCT, ATG, CR, LFS, MSD, NRM, URD |
| 56 |
2013 |
Validation of the EBMT Risk Score for South Brazilian Patients Submitted to Allogeneic Hematopoietic Stem Cell Transplantation. |
HSCT, NRM, OS |
| 57 |
2013 |
[Autologous stem cell transplantation for adult patients with acute lymphoblastic leukemia and related prognostic factors]. |
ALL, ASCT, LFS, WBC |
| 58 |
2013 |
[Outcomes of younger than 60 years old adults with Ph/BCR-ABL positive acute lymphoblastic leukemia: a single center clinical trial of BDH ALL 2000/02]. |
allo-HSCT, ASCT, CR1, DFS, IM, MCR, OS |
| 59 |
2013 |
[Prognostic significance of EBMT score system for hematological malignancies with allogeneic hematopoietic stem cell transplantation]. |
allo-HSCT, OS, TRM |
| 60 |
2012 |
Disease-free survival of patients after surgical resection of non-small cell lung carcinoma and correlation with excision repair cross-complementation group 1 expression and genotype. |
DFS, ERCC1, NSCLC |
| 61 |
2012 |
Effect of release rate of the SF(6) tracer on methane emission estimates based on ruminal and breath gas samples. |
--- |
| 62 |
2012 |
Impact of cytogenetics risk on outcome after reduced intensity conditioning allo-SCT from an HLA-identical sibling for patients with AML in first CR: a report from the acute leukemia working party of EBMT. |
LFS, RIC |
| 63 |
2012 |
Multiple sclerosis and pregnancy: experience from a nationwide database in Germany. |
ARR, DMTs, EBF, GLAT, IFN-beta, MS, NBF, nEBF |
| 64 |
2012 |
[Hematopoietic reconstitution on the prognosis of hematological malignancies after allogeneic hematopoietic stem cell transplantation]. |
allo-HSCT, OS, TRM |
| 65 |
2012 |
[The correlation between early lymphocyte count post-allogeneic hematopoietic stem cell transplantation and prognosis in leukemia patients]. |
aGVHD, allo-HSCT, cGVHD, NRM, OS |
| 66 |
2011 |
Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry. |
allo-SCT, ASCT, DLBCL, NRM, OS, PFS, RIC |
| 67 |
2011 |
Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia. |
ALL, allo-HSCT, BU, CY, GVHD, TRM, VOD |
| 68 |
2011 |
The outcome of high-dose chemotherapy and auto-SCT in patients with multiple myeloma: a UK/Ireland and European benchmarking comparative analysis. |
BSBMT, EBMT, MM, NRM, TTNT |
| 69 |
2011 |
[Clinical analysis of 104 patients with hematological malignancy after allogeneic hemotopoietic stem cell transplantation]. |
aGVHD, allo-HSCT, AML, CML, DFS, OS, TRM |
| 70 |
2011 |
[Relationship between early lymphocyte recovery and prognosis after allogeneic hematopoietic stem cell transplantation for acute leukemia in remission]. |
LC30, NRM, OS, SCT |
| 71 |
2011 |
[The effect of inhibitory and activating natural killer cell immunoglobulin receptor on haplo-identical hematopoietic stem cell transplantation]. |
aGVHD, HSCT, MM, OS |
| 72 |
2010 |
Adjuvant platinum-based chemotherapy in patients with epithelial ovarian cancer: prognostic factors and final outcome. |
CT, OS, OvCa, PFS, PL |
| 73 |
2010 |
High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group. |
AML, DFS, HR, MFI, VLA-4 |
| 74 |
2010 |
Stem cell transplantation using non-myeloablative conditioning regimen with fludarabine for hematological malignancies. |
aGVHD, cGVHD, Flu, NRM, OS, SCT |
| 75 |
2010 |
Tailoring treatment duration to 12 to 16 weeks in hepatitis C genotype 2 or 3 with rapid virologic response: systematic review and meta-analysis of randomized controlled trials. |
ETR, GT, RBV, RVR, SVR |
| 76 |
2010 |
The number of infused CD34+ cells does not influence the incidence of GVHD or the outcome of allogeneic PBSC transplantation, using reduced-intensity conditioning and antithymocyte globulin. |
allo-PBSC, NRM, RIC |
| 77 |
2009 |
Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation. |
AITL, allo-SCT, cGVHD, NRM, OS, PFS |
| 78 |
2009 |
Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study. |
aGVHD, cGVHD, CsA, EFS, GVHD, HSCT, TRM, UD |
| 79 |
2009 |
Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. |
ARR, ART, MS |
| 80 |
2009 |
Neuromyelitis optica in Brazil: a study on clinical and prognostic factors. |
MRI, MS, NMO, PI |
| 81 |
2008 |
Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score. |
APOE, EDSS, MS, MSSS, PI |
| 82 |
2008 |
Indications and results of cord blood transplant in children with leukemia. |
EBMT, UCBT |
| 83 |
2008 |
Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. |
allo-SCT, GVHD, HL, HR, NRM, OS, PFS, RIC |
| 84 |
2008 |
Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study Group. |
AML, DFS, DS, ITD, MLL, OS |
| 85 |
2008 |
[Comparative analysis between autologous and allogeneic hematopoietic stem cell transplantation in 114 adult patients with acute lymphoblastic leukemia in long-term follow-up]. |
allo-HSCT, auto-HSCT, DFS, TRM |
| 86 |
2007 |
Management of acute myeloid leukaemia--5 years experience at Armed Forces Bone Marrow Transplant Centre, Rawalpindi. |
AML, ATRA, CR |
| 87 |
2007 |
Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantation. |
AML, CR, DFS, MA, MDS, non-MA |
| 88 |
2007 |
Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis. |
EDSS, IFN-beta, MS, QUASIMS, s.c |
| 89 |
2007 |
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study. |
EBMT, EFS, OS |
| 90 |
2006 |
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. |
ALL, CI, MRD, PCR, SR |
| 91 |
2006 |
Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study. |
AML, BM, BSBMT, NRM, OS, PBSCs, PFS, TBI |
| 92 |
2006 |
XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children's Oncology Group report. |
AML |
| 93 |
2004 |
Interferon alpha as adjuvant postsurgical treatment of melanoma: a meta-analysis. |
IFN-alpha, OS |
| 94 |
2003 |
[Comparison of curative effect of autologous peripheral blood stem cell transplantation versus bone marrow transplantation for acute leukemia]. |
ABMT, APBSCT, DFS, TRM |
| 95 |
2002 |
High-dose intravenous immunoglobulin treatment of multiple sclerosis. |
--- |
| 96 |
2002 |
Variation in murid Plasmodium desequestration and its modulation by stress and pentoxifylline. |
OT, POF |
| 97 |
2000 |
Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial. |
BMT, Cs-A1, CsA, GVHD |
| 98 |
2000 |
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia? |
GVHD |
| 99 |
1999 |
Autologous peripheral blood stem cell transplantation for acute leukaemias. |
ABMT, ABSCT, AML, DFS, PBSC |
| 100 |
1998 |
Cyclosporine-A as GVHD prophylaxis in allogeneic BMT for childhood acute leukemia. AIEOP-BMT group. |
CSA, CsA1, EFS, TRM |
|
A Search Service for Abbreviation / Long Form
